Glyoxalase 2 correlates with redox signaling and enhances survival outcome in patients with hepatocellular carcinoma

2018 ◽  
Vol 128 ◽  
pp. S71
Author(s):  
Dinh-Truong Nguyen ◽  
Quynh Hoa Tran ◽  
Xuan The Hoang ◽  
Ngoc Huyen Vu ◽  
Kim Van Thi Le ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Redox Signaling ◽  
Survival Outcome ◽  
Glyoxalase 2

scholarly journals Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy

Medicine ◽  
2020 ◽  
Vol 99 (48) ◽  
pp. e23358
Author(s):  
Andrew K.Y. Fung ◽  
Nicole M.Y. Cheng ◽  
Charing C.N. Chong ◽  
Kit-Fai Lee ◽  
John Wong ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Survival Outcome ◽  
Single Center ◽  
Single Center Experience ◽  
Curative Hepatectomy

scholarly journals Factors Associated with the Survival Outcome of Hepatocellular Carcinoma Patients on Supportive Care in a Tertiary Hospital in South-West Nigeria

2019 ◽  
Vol 15 (24) ◽  
Author(s):  
Olusegun Adekanle ◽  
Oluwasegun Ijarotimi ◽  
Akinwumu Oluwole Komolafe ◽  
Samuel Anu Olowookere ◽  
Comfort Olusola Famurewa ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Supportive Care ◽  
Tertiary Hospital ◽  
Survival Outcome ◽  
Factors Associated ◽  
South West

scholarly journals Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome

2018 ◽  
Vol 48 (5) ◽  
pp. 1882-1893 ◽  
Author(s):  
Mohammed Alnaggar ◽  
Mao Lin ◽  
Adnan Mesmar ◽  
Shuzhen Liang ◽  
Ammar Qaid ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Natural Killer ◽  
Nk Cell ◽  
Killer Cell ◽  
Irreversible Electroporation ◽  
Stage Iv ◽  
Clinical Effectiveness ◽  
Survival Outcome ◽  
Cell Immunotherapy

Background/Aims: We evaluated the clinical effectiveness of irreversible electroporation (IRE) in combination with immunotherapy using allogenic natural killer cells (NK) for stage IV hepatocellular carcinoma (HCC). Methods: The study involved 40 patients with stage IV HCC who were divided equally into two groups: 1) simple IRE; and 2) IRE plus allogenic NK cells (IRE-NK); we mainly assessed the overall survival (OS). Results: The effect of the IRE-NK treatment was synergistic, i.e., not only did it enhance immune function, it also decreased alpha-fetoprotein expression and showed significantly good clinical effectiveness. At the median 7.6-month follow-up (range, 3.8–12.1 months), median OS was higher in the IRE-NK group (10.1 months) than in the IRE group (8.9 months, P = 0.0078). Conclusion: IRE combined with allogeneic NK cell immunotherapy significantly increases the median OS of patients with stage IV HCC.

Analysis of Recurrence Pattern and Its Influence on Survival Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma

2007 ◽  
Vol 12 (1) ◽  
pp. 183-191 ◽  
Author(s):  
Kelvin K. Ng ◽  
Ronnie T. Poon ◽  
Chung-Mau Lo ◽  
Jimmy Yuen ◽  
Wai Kuen Tso ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Survival Outcome ◽  
Recurrence Pattern
Sign in / Sign up

Export Citation Format

Share Document